SHOULD every teenager be given a vaccine that blocks the effects of nicotine and so prevents them becoming addicted to the evil weed?
This controversial possibility is on the horizon thanks to the development of two pioneering vaccines for nicotine addiction. The vaccines were designed for people who repeatedly relapse after giving up smoking. But since most countries are failing to cut the number of children and teenagers taking up cigarettes, many will ask if the vaccines should be used far more widely if they prove to be effective.
One, developed by Florida company Nabi Biopharmaceuticals, began safety trials this…
